ELIZABETH BURNS: Open Payments
NPI 1023627577 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,418 in 130 payments from 26 companies in 2025. Trend: 2023 $2,642 · 2024 $3,190 · 2025 $2,418
Food & beverage: $2,358Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $446 |
| ABBVIE INC. | 22 | $408 |
| UCB, Inc. | 15 | $300 |
| E.R. Squibb & Sons, L.L.C. | 10 | $226 |
| Novartis Pharmaceuticals Corporation | 10 | $209 |
| PFIZER INC. | 12 | $191 |
| Mallinckrodt Hospital Products Inc. | 3 | $95 |
| Lilly USA, LLC | 5 | $76 |
| Janssen Biotech, Inc. | 3 | $56 |
| Tandem Diabetes Care, Inc. | 2 | $43 |
Products named: RINVOQ, Bimzelx, ORENCIA, COSENTYX, KRYSTEXXA, XELJANZ, ACTHAR, ENBREL.
Industry payments across AR — which companies pay providers there.
